Literature DB >> 24424381

Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease.

María Lacalle-Aurioles1, José M Mateos-Pérez2, Juan A Guzmán-De-Villoria3, Javier Olazarán4, Isabel Cruz-Orduña4, Yasser Alemán-Gómez5, María-Elena Martino6, Manuel Desco1.   

Abstract

The purpose of this study was to elucidate whether cerebral blood flow (CBF) can better characterize perfusion abnormalities in predementia stages of Alzheimer's disease (AD) than cerebral blood volume (CBV) and whether cortical atrophy is more associated with decreased CBV or with decreased CBF. We compared measurements of CBV, CBF, and mean cortical thickness obtained from magnetic resonance images in a group of healthy controls, patients with mild cognitive impairment (MCI) who converted to AD after 2 years of clinical follow-up (MCI-c), and patients with mild AD. A significant decrease in perfusion was detected in the parietal lobes of the MCI-c patients with CBF parametric maps but not with CBV maps. In the MCI-c group, a negative correlation between CBF values and cortical thickness in the right parahippocampal gyrus suggests an increase in CBF that depends on cortical atrophy in predementia stages of AD. Our study also suggests that CBF deficits appear before CBV deficits in the progression of AD, as CBV abnormalities were only detected at the AD stage, whereas CBF changes were already detected in the MCI stage. These results confirm the hypothesis that CBF is a more sensitive parameter than CBV for perfusion abnormalities in MCI-c patients.

Entities:  

Mesh:

Year:  2014        PMID: 24424381      PMCID: PMC3982085          DOI: 10.1038/jcbfm.2013.241

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Adaptive total linear least square method for quantification of mean transit time in brain perfusion MRI.

Authors:  XingFeng Li; Jie Tian; EnZhong Li; XiaoXiang Wang; JianPing Dai; Lin Ai
Journal:  Magn Reson Imaging       Date:  2003-06       Impact factor: 2.546

Review 3.  Astrocytes function in matching blood flow to metabolic activity.

Authors:  David R Harder; Chenyang Zhang; Debebe Gebremedhin
Journal:  News Physiol Sci       Date:  2002-02

4.  Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load.

Authors:  A Bozzao; R Floris; M E Baviera; A Apruzzese; G Simonetti
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

5.  The effects of changes in PaCO2 on cerebral blood volume, blood flow, and vascular mean transit time.

Authors:  R L Grubb; M E Raichle; J O Eichling; M M Ter-Pogossian
Journal:  Stroke       Date:  1974 Sep-Oct       Impact factor: 7.914

6.  Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.

Authors:  S Nakano; T Asada; H Matsuda; M Uno; M Takasaki
Journal:  J Nucl Med       Date:  2001-10       Impact factor: 10.057

7.  A subanesthetic concentration of sevoflurane increases regional cerebral blood flow and regional cerebral blood volume and decreases regional mean transit time and regional cerebrovascular resistance in volunteers.

Authors:  C Kolbitsch; I H Lorenz; C Hörmann; M Schocke; C Kremser; F Zschiegner; A Löckinger; K P Pfeiffer; S Felber; A Benzer
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

Review 8.  Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Authors:  B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

9.  Regional cerebral perfusion alterations in patients with mild cognitive impairment and Alzheimer disease using dynamic susceptibility contrast MRI.

Authors:  Thomas Hauser; Peter Schönknecht; Philipp A Thomann; Lars Gerigk; Johannes Schröder; Romy Henze; Alexander Radbruch; Marco Essig
Journal:  Acad Radiol       Date:  2013-06       Impact factor: 3.173

10.  Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities.

Authors:  M A Bell; M J Ball
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more
  21 in total

Review 1.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline.

Authors:  Jun Hua; SeungWook Lee; Nicholas I S Blair; Michael Wyss; Jiri M G van Bergen; Simon J Schreiner; Sonja M Kagerer; Sandra E Leh; Anton F Gietl; Valerie Treyer; Alfred Buck; Roger M Nitsch; Klaas P Pruessmann; Hanzhang Lu; Peter C M Van Zijl; Marilyn Albert; Christoph Hock; Paul G Unschuld
Journal:  Neurobiol Aging       Date:  2019-01-10       Impact factor: 4.673

3.  Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.

Authors:  Zhiyou Cai; Zhou Liu; Ming Xiao; Chuanling Wang; Fuming Tian
Journal:  Neurochem Res       Date:  2017-08-24       Impact factor: 3.996

4.  Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment.

Authors:  Chan-Mi Kim; Rachel L Alvarado; Kimberly Stephens; Hsiao-Ying Wey; Dany J J Wang; Elizabeth C Leritz; David H Salat
Journal:  Neurobiol Aging       Date:  2019-11-06       Impact factor: 4.673

5.  Mapping functional connectivity using cerebral blood flow in the mouse brain.

Authors:  Karla M Bergonzi; Adam Q Bauer; Patrick W Wright; Joseph P Culver
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

Review 6.  MRI techniques to measure arterial and venous cerebral blood volume.

Authors:  Jun Hua; Peiying Liu; Tae Kim; Manus Donahue; Swati Rane; J Jean Chen; Qin Qin; Seong-Gi Kim
Journal:  Neuroimage       Date:  2018-02-16       Impact factor: 6.556

Review 7.  Brain imaging of neurovascular dysfunction in Alzheimer's disease.

Authors:  Axel Montagne; Daniel A Nation; Judy Pa; Melanie D Sweeney; Arthur W Toga; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2016-04-01       Impact factor: 17.088

8.  Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients.

Authors:  Miranka Wirth; Alexa Pichet Binette; Peter Brunecker; Theresa Köbe; A Veronica Witte; Agnes Flöel
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

9.  Reduced global brain metabolism but maintained vascular function in amnestic mild cognitive impairment.

Authors:  Binu P Thomas; Min Sheng; Benjamin Y Tseng; Takashi Tarumi; Kristen Martin-Cook; Kyle B Womack; Munro C Cullum; Benjamin D Levine; Rong Zhang; Hanzhang Lu
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

10.  Guiding functional connectivity estimation by structural connectivity in MEG: an application to discrimination of conditions of mild cognitive impairment.

Authors:  José Angel Pineda-Pardo; Ricardo Bruña; Mark Woolrich; Alberto Marcos; Anna C Nobre; Fernando Maestú; Diego Vidaurre
Journal:  Neuroimage       Date:  2014-08-08       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.